Glycosylphosphatidylinositol biosynthesis validated as a drug target for African sleeping sickness
AUTOR(ES)
Ferguson, Michael A. J.
FONTE
The National Academy of Sciences
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=34041Documentos Relacionados
- Chemical validation of GPI biosynthesis as a drug target against African sleeping sickness
- Trypanosoma brucei CTP synthetase: A target for the treatment of African sleeping sickness
- African sleeping sickness
- Galactose metabolism is essential for the African sleeping sickness parasite Trypanosoma brucei
- History of Sleeping Sickness in East Africa